Abstract
This population-based case–control study of African-American women (355 breast cancer case patients, 327 controls) examined the association between breast cancer and circulating levels of PCBs and dichlorodiphenyldichloroethene (DDE), a metabolite of DDT. Case patients were diagnosed with invasive breast carcinoma and interviewed between June 1995 and July 1998, and control subjects were identified by random digit dialing methods. Serum levels of DDE and total PCBs were adjusted for total lipid content. Odds ratios (ORs) and 95% confidence intervals (CIs) were estimated using multivariable unconditional logistic regression methods. Effect modification by tumor receptor status and cancer treatment was investigated. Breast cancer risk was not associated with increasing quintiles of lipid-adjusted PCBs or DDE (highest versus lowest quintile adjusted for age, body mass index (BMI) and breastfeeding for DDE: OR = 1.02, 95% CI = (0.61, 1.72), p-trend = 0.74; for PCBs: OR = 1.01, 95% CI = (0.63, 1.63), p-trend = 0.56). Risk did not differ by strata of BMI, breastfeeding, parity, menopausal status or tumor receptor status. This study, the largest study of African-American women to date, does not support a role of DDE and total PCBs in breast cancer risk at the levels measured.
Similar content being viewed by others
References
SEER. (www.seer.cancer.gov) SEER*Stat Database: Incidence – SEER 9 Regs Public-Use, Nov 2004 Sub (1973–2002), National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch. Released April 2005, based on the November 2004 submission
IARC (1999) Hormonal contraception and postmenopausal hormonal therapy. IARC monographs on the evaluation of carcinogenic risks to humans, Lyon
Brinton LA, Brogan DR, Coates RJ, Swanson CA, Potischman N, Stanford JL (1998) Breast cancer risk among women under 55 years of age by joint effects of usage of oral contraceptives and hormone replacement therapy. Menopause 5(3):145–151
LM Butler NA Potischman B Newman et al. (2000) ArticleTitleMenstrual risk factors and early-onset breast cancer Cancer Causes Control 11 IssueID5 451–458 Occurrence Handle10877338 Occurrence Handle10.1023/A:1008956524669 Occurrence Handle1:STN:280:DC%2BD3cvpt1CisQ%3D%3D
Adami HO, Lipworth L, Titus-Ernstoff L, et al (1995) Organochlorine compounds and estrogen-related cancers in women. Cancer Causes Control 6(6):551–566
Longnecker MP, Rogan WJ, Lucier G (1997) The human health effects of DDT (dichlorodiphenyltrichloroethane) and PCBS (polychlorinated biphenyls) and an overview of organochlorines in public health. Annu Rev Public Health 18:211–244
Ahlborg UG, Lipworth L, Titus-Ernstoff L, et al (1995) Organochlorine compounds in relation to breast cancer, endometrial cancer, and endometriosis: an assessment of the biological and epidemiological evidence. Crit Rev Toxicol 25(6):463–531
Dich J, Zahm SH, Hanberg A, Adami HO (1997) Pesticides and cancer. Cancer Causes Control 8(3):420–443
Kimbrough RD, Krouskas CA (2003) Human exposure to polychlorinated biphenyls and health effects: a critical synopsis. Toxicol Rev 22(4):217–233
Unger M, Kiaer H, Blichert-Toft M, Olsen J, Clausen J (1984) Organochlorine compounds in human breast fat from deceased with and without breast cancer and in a biopsy material from newly diagnosed patients undergoing breast surgery. Environ Res 34(1):24–28
Falck F, Jr, Ricci A, Jr, Wolff MS, Godbold J, Deckers P (1992) Pesticides and polychlorinated biphenyl residues in human breast lipids and their relation to breast cancer. Arch Environ Health 47(2):143–146
Wassermann M, Nogueira DP, Tomatis L, et al (1976) Organochlorine compounds in neoplastic and adjacent apparently normal breast tissue. Bull Environ Contam Toxicol 15(4):478–484
Mussalo-Rauhamaa H, Hasanen E, Pyysalo H, Antervo K, Kauppila R, Pantzar P (1990) Occurrence of beta-hexachlorocyclohexane in breast cancer patients. Cancer 66(10):2124–2128
Dewailly E, Dodin S, Verreault R, et al (1994) High organochlorine body burden in women with estrogen receptor-positive breast cancer. J Natl Cancer Inst 86(3):232–234
Aronson KJ, Miller AB, Woolcott CG, et al (2000) Breast adipose tissue concentrations of polychlorinated biphenyls and other organochlorines and breast cancer risk. Cancer Epidemiol Biomarkers Prev 9(1):55–63
Millikan R, DeVoto E, Duell EJ, et al (2000) Dichlorodiphenyldichloroethene, polychlorinated biphenyls, and breast cancer among African-American and white women in North Carolina. Cancer Epidemiol Biomarkers Prev 9(11):1233–1240
van’t Veer P, Lobbezoo IE, Martin-Moreno JM, et al (1997) DDT (dicophane) and postmenopausal breast cancer in Europe: case–control study. BMJ 315(7100):81–85
Zheng T, Holford TR, Mayne ST, et al (2000) Risk of female breast cancer associated with serum polychlorinated biphenyls and 1,1-dichloro-2,2′-bis(p-chlorophenyl)ethylene. Cancer Epidemiol Biomarkers Prev 9(2):167–74
Woolcott CG, Aronson KJ, Hanna WM, et al (2001) Organochlorines and breast cancer risk by receptor status, tumor size, and grade (Canada). Cancer Causes Control 12(5):395–404
Gammon MD, Wolff MS, Neugut AI, et al (2002) Environmental toxins and breast cancer on Long Island. II. Organochlorine compound levels in blood. Cancer Epidemiol Biomarkers Prev 11(8):686–697
Engel LS, Hill DA, Hoppin JA, et al (2005) Pesticide use and breast cancer risk among farmers’ wives in the agricultural health study. Am J Epidemiol 161(2):121–135
Krieger N, Wolff MS, Hiatt RA, Rivera M, Vogelman J, Orentreich N (1994) Breast cancer and serum organochlorines: a prospective study among white, black, and Asian women. J Natl Cancer Inst 86(8):589–599
Laden F, Collman G, Iwamoto K, et al (2001) 1,1-Dichloro-2,2-bis( p-chlorophenyl)ethylene and polychlorinated biphenyls and breast cancer: combined analysis of five U.S. studies. J Natl Cancer Inst 93(10):768–776
Muscat JE, Britton JA, Djordjevic MV, et al (2003) Adipose concentrations of organochlorine compounds and breast cancer recurrence in Long Island, New York. Cancer Epidemiol Biomarkers Prev 12(12):1474–1478
Raaschou-Nielsen O, Pavuk M, Leblanc A, et al (2005) Adipose organochlorine concentrations and risk of breast cancer among postmenopausal Danish women. Cancer Epidemiol Biomarkers Prev 14(1):67–74
Hoyer AP, Gerdes AM, Jorgensen T, Rank F, Hartvig HB (2002) Organochlorines, p53 mutations in relation to breast cancer risk and survival. A Danish cohort-nested case–controls study. Breast Cancer Res Treat 71(1):59–65
Wolff MS, Zeleniuch-Jacquotte A, Dubin N, Toniolo P (2000) Risk of breast cancer and organochlorine exposure. Cancer Epidemiol Biomarkers Prev 9(3):271–277
Wolff MS, Toniolo PG, Lee EW, Rivera M, Dubin N (1993) Blood levels of organochlorine residues and risk of breast cancer. J Natl Cancer Inst 85(8):648–652
Stehr-Green PA, Farrar JA, Burse VW, Royce WG, Wohlleb JC (1988) A survey of measured levels and dietary sources of selected organochlorine pesticide residues and metabolites in human sera from a rural population. Am J Public Health 78(7):828–830
Zheng T, Holford TR, Mayne ST, et al (1999) DDE and DDT in breast adipose tissue and risk of female breast cancer. Am J Epidemiol 150(5):453–458
Rogan WJ (1996) Pollutants in breast milk. Arch Pediatr Adolesc Med 150(9):981–990
Stehr-Green PA (1989) Demographic and seasonal influences on human serum pesticide residue levels. J Toxicol Environ Health 27(4):405–421
Schildkraut JM, Demark-Wahnefried W, DeVoto E, Hughes C, Laseter JL, Newman B (1999) Environmental contaminants and body fat distribution. Cancer Epidemiol Biomarkers Prev 8(2):179–183
Marchbanks PA, McDonald JA, Wilson HG, et al (2002) The NICHD women’s contraceptive and reproductive experiences study: methods and operational results. Ann Epidemiol 12(4):213–221
Waksberg J (1978) Sampling methods for random digit dialing. J Am Stat Assoc 73:40–46
Norman SA, Berlin JA, Weber AL, et al (2003) Combined effect of oral contraceptive use and hormone replacement therapy on breast cancer risk in postmenopausal women. Cancer Causes Control 14(10):933–943
Longnecker MP, Bernstein L, Bird CL, Yancey AK, Peterson JC (1996) Measurement of organochlorine levels in postprandial serum or in blood collected in serum separator tubes. Cancer Epidemiol Biomarkers Prev 5(9):753–755
Sherma J (1980) Manual of analytical methods for the analysis of pesticides in humans and environmental samples. Health Effects Laboratory; Research Triangle Park, NC
Burse VW, Korver MP, Needham LL, et al (1989) Gas chromatographic determination of polychlorinated biphenyls (as Aroclor 1254) in serum: collaborative study. J Assoc Off Anal Chem 72(4):649–659
Webb RG, McCall AC (1973) Quantitative PCB standards for electron capture gas chromatography. J Chromatogr Sci 11(7):366–373
Erickson MD (1997) Analytical chemistry of PCBs. 2nd ed. Lewis, New York
Takayama M, Itoh S, Nagasaki T, Tanimizu I (1977) A new enzymatic method for determination of serum choline-containing phospholipids. Clin Chim Acta 79(1):93–98
McGowan MW, Artiss JD, Strandbergh DR, Zak B (1983) A peroxidase-coupled method for the colorimetric determination of serum triglycerides. Clin Chem 29(3):538–542
Beckman Instruments I (1993) CS-7 Operations Manual. Beckman Instruments, Inc. Irvine, CA
Richmond W (1973) Preparation and properties of a cholesterol oxidase from Nocardia sp. and its application to the enzymatic assay of total cholesterol in serum. Clin Chem 19(12):1350–1356
Phillips DL, Pirkle JL, Burse VW, Bernert JT, Jr, Henderson LO, Needham LL (1989) Chlorinated hydrocarbon levels in human serum: effects of fasting and feeding. Arch Environ Contam Toxicol 18(4):495–500
Press M (1993) Estrogen and progesterone receptors in breast cancer. Adv Pathol Lab Med 6:117–148
Wen WH, Reles A, Runnebaum IB, et al (1999) p53 mutations and expression in ovarian cancers: correlation with overall survival. Int J Gynecol Pathol 18(1):29–41
Lukas J, Niu N, Press MF (2000) p53 mutations and expression in breast carcinoma in situ. Am J Pathol 156(1):183–191
Saffari B, Bernstein L, Hong DC, et al (2005) Association of p53 mutations and a codon 72 single nucleotide polymorphism with lower overall survival and responsiveness to adjuvant radiotherapy in endometrioid endometrial carcinomas. Int J Gynecol Cancer 15(5):952–963
Press MFSB, Groshen S, Kaminsky D, et al (2002) Monoclonal antibodies designed for immunohistochemical detection of progesterone receptor in archival breast cancer specimens. Steroids 67:799–813
Press MF, Slamon DJ, Flom KJ, Park J, Zhou JY, Bernstein L (2002) Evaluation of HER-2/neu gene amplification and overexpression: comparison of frequently used assay methods in a molecularly characterized cohort of breast cancer specimens. J Clin Oncol 20(14):3095–105
Press MF, Sauter G, Bernstein L, et al (2005) Diagnostic evaluation of HER-2 as a molecular target: an assessment of accuracy and reproducibility of laboratory testing in large, prospective, randomized clinical trials. Clin Cancer Res 11(18):6598–607
Park JM, Yang X, Park JJ, Press OW, Press MF (1999) Assessment of novel anti-p185HER-2 monoclonal antibodies for internalization-dependent therapies. Hybridoma 18(6):487–495
Press M, Spaulding B, Groshen S, et al (2002) Comparison of different antibodies for detection of progesterone receptor in breast cancer. Steroids 67(9):799–813
Bernstein L (2006) Control recruitment in population-based case–control studies. Epidemiology 17(3):255–257
Coradini D, Daidone MG (2004) Biomolecular prognostic factors in breast cancer. Curr Opin Obstet Gynecol 16(1):49–55
Mass RD (2004) The HER receptor family: a rich target for therapeutic development. Int J Radiat Oncol Biol Phys 58(3):932–940
Sledge GW, Jr (2004) HERe-2 stay: the continuing importance of translational research in breast cancer. J Natl Cancer Inst 96(10):725–727
Anderson E (2002) The role of oestrogen and progesterone receptors in human mammary development and tumorigenesis. Breast Cancer Res 4(5):197–201
Dickson RB, Stancel GM (2000) Estrogen receptor-mediated processes in normal and cancer cells. J Natl Cancer Inst Monogr 2000(27):135–145
Gammon MD, Wolff MS, Neugut AI, et al (1996) Treatment for breast cancer and blood levels of chlorinated hydrocarbons. Cancer Epidemiol Biomarkers Prev 5(6):467–471
Henderson BE, Feigelson HS (2000) Hormonal carcinogenesis. Carcinogenesis 21(3):427–433
Rusiecki JA, Matthews A, Sturgeon S, et al (2005) A correlation study of organochlorine levels in serum, breast adipose tissue, and gluteal adipose tissue among breast cancer cases in India. Cancer Epidemiol Biomarkers Prev 14(5):1113–1124
Rogan WJ, Gladen BC, McKinney JD, et al (1986) Polychlorinated biphenyls (PCBs) and dichlorodiphenyl dichloroethene (DDE) in human milk: effects of maternal factors and previous lactation. Am J Public Health 76(2):172–177
DeVoto E, Fiore BJ, Millikan R, et al (1997) Correlations among human blood levels of specific PCB congeners and implications for epidemiologic studies. Am J Ind Med 32(6):606–613
Newcomb PA (1997) Lactation and breast cancer risk. J Mammary Gland Biol Neoplasia 2(3):311–318
Kutz FW, Yobs AR, Strassman SC (1977) Racial stratification of organochlorine insecticide residues in human adipose tissue. J Occup Med 19(9):619–622
Bernstein L, Teal CR, Joslyn S, Wilson J (2003) Ethnicity-related variation in breast cancer risk factors. Cancer 97(1 Suppl):222–229
Acknowledgments
This study was supported by the National Institute of Child Health and Human Development, with additional support from the National Cancer Institute (NCI), through a contract with the University of Southern California University of Southern California (N01 HD 3–3175), by a grant from the National Institute of Environmental Health Sciences (NIEHS), ES07084, and in part by the Intramural Research Program of the National Institutes of Health, NIEHS. General support from NCI through the SEER Program contract to the Cancer Surveillance Program for Los Angeles County (N01-CN-67010) is also acknowledged. The collection of cancer incidence data for Los Angeles County used in this publication was also supported by the California Department of Health Services as part of the statewide cancer reporting program mandated by the California Health and Safety Code Section 103885. The ideas and opinions expressed herein are those of the authors, and no endorsement by the State of California, Department of Health Services, is intended or should be inferred.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gatto, N.M., Longnecker, M.P., Press, M.F. et al. Serum organochlorines and breast cancer: a case–control study among African-American women. Cancer Causes Control 18, 29–39 (2007). https://doi.org/10.1007/s10552-006-0070-2
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s10552-006-0070-2